BWM
FLNA

BerganKDV Wealth Management’s Filana Therapeutics FLNA Stock Holding History

BerganKDV Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$1.23K Hold
50
– – ﹤0.01% 736
2023
Q1 		$1.21K Hold
50
– – ﹤0.01% 886
2022
Q4 		$1.48K Hold
50
– – ﹤0.01% 837
2022
Q3 		$2K Hold
50
– – ﹤0.01% 832
2022
Q2 		$1K Hold
50
– – ﹤0.01% 929
2022
Q1 		$2K Hold
50
– – ﹤0.01% 873
2021
Q4 		$2K Hold
50
– – ﹤0.01% 932
2021
Q3 		$3K Buy
+50
New +$4.17K ﹤0.01% 840

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BerganKDV Wealth Management's FLNA Position: Q2 2023 in Review

BerganKDV Wealth Management held its Filana Therapeutics (FLNA) position steady in Q2 2023 at 50 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

BerganKDV Wealth Management first reported a position in FLNA in Q3 2021 and has held it in 8 quarters since. The position peaked at $3K in Q3 2021. 152 funds tracked by Wall St. Rank hold FLNA as of Q2 2023.

  • BerganKDV Wealth Management held 50 shares of Filana Therapeutics worth $1.23K as of Q2 2023.
  • BerganKDV Wealth Management left its Filana Therapeutics share count unchanged in Q2 2023.
  • Filana Therapeutics made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #736 holding.
  • BerganKDV Wealth Management first reported a position in Filana Therapeutics in Q3 2021 and has held it in 8 quarters since.
  • BerganKDV Wealth Management's Filana Therapeutics position peaked at $3K in Q3 2021.
  • 152 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.